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SUMMARY CONCLUs IONS A DFUTURE P RSPECTIVES
( l lstro-oesophlgeal ref lux disease (CiC)RD) is a \rerv cornrnon disorclel c.rurinq
syl l f i ronrs l ike heartburn, belching rrnd rcgurgitat ion, peinÍul fbocl fr lssage, or cven
h:rnrperccl f i rocl passage , depenc{ing on the severitv . i f  thc ref lux, the sensit ivi ty oÊ thc
ocsophagcal nrucosa:rnt l :rn1'po.ssible changcs in the irnirtoml..  In thc normrrl  poptr let ion
nrrurv neecl acicl neutlal izing, acid supprcssive, or prokinct ic cl lugs, ci thcr (rr pre\cripri( ,n
or "ovcr t i rc courrter". ( IORD, horvcver is more than heartburn, problerrs with f-ood
irr lssage or ocsopheqit is. 
' fhcre 
i l re extra-ocsophaeeal, in p:rrt iculrrr rcspiratory
lnenifèst:rt ions: anc1, for sonre, there is an increascd r isl< to develop cirncer. l 'his thesis is
rbout t l ' rese rwo aspects of GOli l) .
A combined action of ( lC)R. neural rcf lcxcs ancl thc rele:r.se of active srrbstances in the
ulrpcr:rero-cl iqestivc tr irct seerns to incluce or irgl lravate r irwav cl iscme, both on eirr-nose-
rhrorrt lei 'el  ,rncl on tracheo-bronchi:r l  level.  l  hough the sl,nrptorns hrle been alreatly
clescri lret l  a long t irnc ago, halcl Êrcts ar-rd sol icl  f igules have bcen sclfcc or contradicton' lor
nlr lny l ,eeri^. Chapter I  gives an ovcrr. ' iew olt  the proble rn of so-cal lcd qirstr ic :rsthnra.
Sr. 'nrpromrrtologl.  lnd cl irr ical outconre àre thc cndpoints in nrany sttrdies.
l) :r thophl 'siological lv two mechrrnisms hirve been str,rdicc{ by sever:r l  researchcrs:
microaspirat ion of rcÍ lr .rxcd gastr ic contents into t lre rr irrvavs, rucl veg:tt l r" transnrit tecl
ref lexes, le:rding to brcnchoconstr ict ion. A third mechanism is less rvel l  cxaninetl :  thc
increase of airway h1'perrc.^ponsi\rcness, po.ssibly due to:r hcightened v:rgel tone or thc
associ l tecl rcleasc of inf lammatorv rnedi:rtors. lntervcntion stucl ies, troth nrecl ical and
surgicl l ,  have not becn unccpivocal. Neverthelcss, thcrc is a qroup of patier-rts rvi th both
:rsrhma end G()RD, rvho rnay bcncfi t  f lonr anti-aci. l reÍ1ux t l-rerapr' fhcse .rre the pl l icnrs
*' i th cl i fhcult  to trcrt r lsthnra, rrclult  onset asthma ancl rrorr-rr l lergic ast lrnr:r.  In cl inical
practicc the ain'r of thcrepy is heal ing of a disea.se, or i f  ini ;rossible ir lprovemcut of
svrnptonratokr!1,.  Svn'rptonrs howcver, are bv c{ef init ion subjective. In aclcl ir i ,rn ro
symptonlsl objectivc Ínci lsurcs arc neeclcd. Chapter I I  reports the resLrlts of our clouble-
bl incl ranriomiz.cd plospective studl ' .  A grotrp of asthma and COPD patier.rts rvi th severe
airwey ht'perrcsponsir.'encss ancl incrcrrsecl acicl glstro-ocsophaeeal rL'flux \\,irs treatecl n'ith
profbr,rncl acid supplessive mccl icat ion, orneprlzolc 40 nrg b. i .d. for t l -rrce lnonths or lr ' i rh
plecebc'r.  ' l reatmcnt u' i tb orneprazole cl icl  not improve airwav hvperresponsiveness (:rs
rncrrsurcd bv a fal l  of 20% in FL,Vr after nreth:rchol inc clral lcnge), or any of the ot lrcr tcstecl
resl.r i latorl 'prrr irnreters, l ike peak expiratorv f ' low (Plr l i ) ,  vi tal capacity, ancl rcvcrsibi l i ry by
ipmrro;-r iunr bromicle. 'W'i th regard to symptorns, only' l reartburn improvecl sienif icantly
*4rereas respiratorv syr-nptoms cl icl  not. In conclusion the rcsults clo not support a role in
generel Íor intensive lr l t i -ref lu\ thcrapy,i tr  asthnra or COPD patients r l ' i th severc airwav
hvperresponsivenL'ss.
( luinea pig expcrimcnts havc .shorvn reccr-rt ly thlr oesophagcal st imulat ion rvith
hyc{rochloric acid crurses e ncunrge nic inÍ latntnlt ion of the ainvavs, th:rt  \ \ 'a.s nrcdiated by
the relea.se oFactivc subst:rnces, inclucl ing probablv substance It ,  via e neural pathway
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summary, concrusions * *'!i1[lï,i"1
(l()RI) :rppcar to frar.c synrptoms of :rutonornic dysfunction w'ith a l-reigl-rtened v:rgal tonc,
rvlr ich rnru'tre a frrctor in the airway response to acid ref lux [2].  T'his explanerion is,
holr '* 'ct cot.tsicicred inrprobable b1'othels [3J. A large epiclerniological sttrdv birsetl  on
qtrestionnaires lrorved that G()R symptor-ns and bror-Lchial hyper-responsiveness (as rvel l  as
ir l i table borvcl synclrotne) occur more often together rhan expectcd [4].  - l 'he investigators
expl l in this f inding not u, i th :r causal rclat ion, but u, i th l  col 'nnron, sr i l l  unknorvn, caLrsal
factor that ptodtrces s\/mptonls in nrorc th;rn one system. Cancl idates could be a
drsf irnct ion in smootl ' r  rnrrscle, à nel lromuscular cl isorder, or a shared inf lan-rmntory
le t iologv.
So with rcgarci to gastric asthma: ivhich paticnts beneflt most from anti-ref-L-rx
ntct l icrrt ion? If  the prcvalence of (IC)RD is so high in asthrnatics, why do so fèrv benefi t
f iom (l()R-cl i tcctccl thcrapy? Vlrar is nceclecl is a bcttcr characterization of the frrf icnts,
rnd tnore irrsight in the pathophysiology. - l 'herc must bc more than a simple v,rgal ref lex
ancl micloasl 'r i ret ion. \ \ /het is the role of rhe non-acirenergic non-chol inergic (NANC)
innen'arion? V hat is thc exact role of nitr ic oxide (NC)), synthesizcd bi '  ei ther consti tut ivc
or indLrcible nitr ic r.rxicle svnthase (c-N()S and i- NOS)? Inf lamnratory'  mcdiators are
relclsecl,  but crtn \ \ 'e coLl lr ter: lct their act ion or suppress thcir rclease? For the t imc being,
thcrc is no necd to rrcar every rrsthrnaric For (]C)RD. But one has ro think of i t  in case of
r i i f l icLrl t  to trert: lsthnra, adult onset asthr-na, nor-r-al lergic asthma, and uiavbe in casc of
night t ime aggr:rvations; thi.s count.s when there are no wpic,r l  CiC)R syrnptorr-rs. ()bviouslv
the prt icnt needs to bc ex,rmined for GORD r'vhen there rrrc q,pical syÍnptoms, and to be
tre:rted aclequatelr'. It mav be sor.novhat disappoir.rting, but onc has to be sarisflecl witl.r
s\.nrptorn irrtpt 'ovcnrent onlr. ' ,  rvi thout any obiectiye improvenrenr in lung ftrnct ion l5l.
Chaptet I I I  cont:r ins an overvierv of l i terature on Barrett 's oesophagus (BO) and
ecicnocarcinoma of the oesopl-ragr:s. I IO is causcd by chronic l ia.\ tro-oe.sophagcal acid
rcf lux. ' l -hc lolc of duoden:r l  rcf- lux is controversi ir l .  BO is characterizecl by colur.nnirr
ntetapl:r.si :r  of the epithel ium. l 'hree types of nretaplasia can be rccognized: the special iz.ed
or intest inai tvpe, the eestl ic- juncrional ol clrdi:r  type, and r lrc gastr ic-fundic g'pe. More
rccently thc clef lnir ior.r of B() has been restr ictcd to colunrnar n.retaplasia of thc special ized-
intestinal r lpc w,i th i ts 1.;at l .rognomonic goblet cel ls [6].  The incidcnce of rdenocarcinoma
t-,f  cardia,rncl oesoph,rgus is increasing. Ptrt icnrs with BO l.rave a -10 ar 125-fbld increased
risk tor oesophaqeal aclenoclrcinoma compared with the qeneral populat ion. -I i rmours
develop fr 'onr special ized-intestir .ral n,pe nretapl:rsia wirh lor '" ,-sradc dysplasia and hieh-gradc
dvsplasia as intcrmediate st irges. 1'his histological change is co a certain degrce accompaniecl
try qenonric instabi l i tv rvi th rneuploidv and increasecl G2ltetraploid fr ' :rct ions.
Overexpression of the p53 i ;rotein. clue to a mutation of the p53 gene is often seen in high-
srade clvsplasia nrl  cancer. In several stLldies increascd epithel ial cel l  plol i fèrat ion was
foLrntl  in d1'spla-sia ancl adenocarcinoma. Moreover in a fèw studies cel l  prol i Í i ' rat ion was
hiche r in intest inal rype thárÍr in gastl ic q'pc metaplasia. N{ore or less paral lel to the
prol i fèrat ion rate, rn increase in the expression of the rransforming growtlr Í i rctor alpha
(l 'GF-tx) 












Oesophagir is and BL) are caused by ref lux of gastr ic contents into the oesophaeus, of
rvhich acid is the most harmÍir l  component. Chemotherapv cirn incluce nrucosit is of the
(l l- tract, especial l l '  c l f  the n-routh irnd of the oesophagr.rs. Some investigators olrserved thc
developrnent of l lO in prt ients treared with che motherapv for bre:rst c:rncer. In Chapter IV
the results of our sttrdy, on this subject are presented. ()ur studv populat ion corrsisted of
nvo groups: one group n' i th tcsriculer clrcinoml lor lvl ' r ich thel '  1vsy. trcated wirh highlv
cn-retogenic hemotherapyl and another with breast cancer treatecl with high dose
chenrotherapl '  with subseqtrcnt rnucorir is, in Preparation fbr lutologons bonc nrarrow
tr:tnspl,rntarion. Fortunatelv rvc found no ir-rct 'clsed prcvalet 'rcc of BO in both grouprs.
Othcrs crrnle àt about thc s:rme t ime as wt: to the s:rme c<.rnclu.sion, checking on acl j trvant
chemotl-rerapy fbr breast cancer {71. ' l 'hus scrcening Íbr B() after chemother.rpf i .  not
generrl l f  indicated.
In nornnl irealthy t issue there is a ciel icate halance betwecn ccl l  prol i fèrat ior-r:rnd
programnrecl cel l  cleath (apoptosis). Both phenon-ren'.r r l e uncler the inf lr-rencc oi manl
regtr lr torv rrrcchiurisms, rvi th rtmong orher rhings rLrt()cr inc, prrrrcr i l )c,rncl genetic aspccts.
L-r prernai igr-rar-rt  anci rnal iglr lr Ír t  issue thesc mechanisms rtre distr,rrbeci,  Ieading ro increasc<l
ccl l  prol i fèrarion and alterccl apoptosis. In Chapter V rve report our rncthoclology of
rne,rsuring epithel ial ccl l  prol i fèret ivc activi ty in l lO, and i ts correlat ion with acccpred
cancer r isk m:rrkers. Incorporation in uitro of 5-bronrocleoxvuricl  ne (LlrclU) irr to thc
nucleus is cornperablc rrncl equivalent to the incorporation of tr i t iatec] rhvnridine; both are
incorporatecl into t l .r . :  DNA ciLrr ing the S-phase of t l .rc cel l  o,cle. ' fhc advantage of the
BrclU technique is that no radioactive nraterials lrc used, ancl thrrt  rhe latrel is in the r issuc
itsclf .  r 'v i th the possibi l i ry to relate label ing direct lv w' i th r. t ' rorphologv. ' I 'he encioscopical lv
taken biopsics werc enrbe.lded in glycol nlcthacrvlate ( lechnovit 8100). Sl icles of 2 ; tm
tl-r ick were r-rsed for immr.rnol-r istochemical deteccion oÍt BrclU, fbr hcmatoxyl in-eosin
(H&F) anc' l  frrr perioc{ic acid-Schiff  (PAS) sraining. ln each san.rplc 4000 nr-rcleated Iunrinal
epirhcl ial  cel ls and 4000 nucleatcd crvpt cel ls were countecl.  Clrypt anc{ surfnce cpithel iurl
label ing index (LI) wcre detcrnrinecl .separ,rtelv in biopsies takcn f i 'or.rr cl i f ïerent levels of
BO. ' l -hc length of.BO correlatcd posit ivel l 'u, i t l r  the scverity oÍ erccr acicl ref lux. lntcr-
:rnd inrr,r-observer vari ir t ion in l . l  dctermination were w,i thin acceprablc l i rnits.\rX/e Íround
the [. ]  increasing Írom qastr ic- l tr ,rndic to gastr ic- iunctional to intest inrr l-spccial ized
rnctaplasir. ' fhc dif fèrcnce \\ 'as st ir t ist ic:r l ly signif . icar.rt  for cr lpt cpithel iurn. We f irund a
highcr Lt rr thc surfàcc in case of dvspl:rsia compared to no dvsplasia, ancl in the more
cl istal part of B(). ( irvpr LI rvas colrelatcd with the leIrgt l-r of BO, arrcl rvi th the type of R()
nreta;r l :rsia. So the Ll corrclatecl rvi th well-knowr-r isk lactors for Lhrrett 's carcinorna. This
nrethocl of measuring prol i ferarion appexrs to be a rel iahle tool ancl hencc mrry be r val i . l
intcrnrediate rnarkcr fbr intcrvention studies.
There is a posit ivc correlat ion betwee n the le ngth of BC) and thc r isk Í tor ,rcleno-
crrrcinonra. l-here is also a correl:r t ion bctu'ecn length of BO and the severit l ,of ,rcicl  ref ' lux.
According to this l ine of rcasonir.rg control of acid lcf lux r.night incluce rcgression of BO,
rnd decrcase cancer r isk. ln Chapter\t I ,  VII and VIII  vv'e report our clata of an
intervcntion studtr We perfbrrnecl a ranclonrized ouble-bl ind prospective study in which
prlticnts rvith IIC) anrl acicl teÍ'lux werc trL-atecl in parallel groups for rwo years r'vith cither
orneprazo lc  40  ms b . i . c l .  o r  w i th  ran i t i c l ine  150 mg b . i .d . .  l rea tnren t  rv i th  h ieh  dosc
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otneprazole cl irninatecl acid ref- lux:r lnrosr conrplercly, rvhereas trcatnrcnt n' irh ranit idine in
this conventional dose resulted in an acceptlblc s1'mptorn reduction rvith a sri l l
pathologically increased acid reflux pefcentage. Endoscopic reglession rvas assessed in
lengrlr ls wcl l  as in ;rre:r of BO. I-ength is relat ivcly e:rsy to rneasure, relat ing the cl istances oÍ
al l  " landr-narks" to the incisors. ' fhe scluamo-colunrn,lr  j .Lnction can howevcr be rather
irregular in BO, wirh ishnds of squarnous epithel iunr in B(), ancl islands of meraplasia in
s(lualnoLrs epit lrcl ium. Wherc others counted islands, we tacklcc] this problcm by nraking
clnwings of BO during endoscopy, f iom which wc ci l lculatcd thc:rrcr of l l () ,  as describcd
in chapter VI. \7e Íirund a small but ste:rdy decrerlse in tsO duling treatnretrr with
omeprazolc: 8o/o in two years which $.as stat ist ical ly signif icant. In the ranit idinc p:rt icnts
no change ir-r lcngth or area of B() was obselved. Indecd the otrserved clecrease is snral l ,  ancl
lve do not kr-row whethcr tl-ris irnprovement rvill continue be,vond tirc trvo study vears wirh
conrinuation of rnecl icat ion. But sincc regression occurrcd graduir l ly ciul ing the tw<l ycars, a
f irrther recltrct ion of BO may be expected. A combinetion of sonte fbrm of mucosrl ablat ion
(for instrnce by mcans of heatcr probc, laset, or argon plastna coagulat ion) n' irh strong acid
suppressiorr rnay lead to better results. as i t  is reported bv othcrs. Unfbrtr,rnately, despite thc
prornising results, i t  was fbuncl that in 30%r colurnn,rr rrretaplasia wais st i l l  prcsent hidden
unc le r  the  over ly ine  squamol rs  ep i thc l ium [8 -11 ] .
(hncer r isk rcductiou r-night Lre achier.ed by nracroscopic reglession of BO, i t  rn:ry aiso
bc achicvecl by changes fbr the better in BO itsclf ,  represcntecl by a reduction ofcel l
prol i fèrat ive activi ty. In the same rwo groups of paticr-rts in this clor.rblc bl ind prospcctive
studv we measured tfre ccl l  prol i fèrat ive activi ty in BO, using irz e, lr lo label ing with BrciU.
The study period was 24 months, clul ir .rg wl.r ich the patients r.vere treated rvith either
omeprazole 40 mg b.i .cl .  or ranit idine 150 rng b. i .d. ( lel l  prol i fèrat ion w:rs nreasurcd ir .r
biopsies, taken at 0,3,9, l l r td24 moÍrths. We asscssed the Ll in the lorvest ( i .e. .)  cm above
the qrstro-ocsophageal junction) ancl thc hishest ( jr .rst Lrelow rhc Z-l ine) taken biopsv of
I l() ,  For the lunrinal part:rnc1 thc crvpt parr separ;rtely. ln chapter VII lve reporr thc rcsults.
In the low'er biopsy wc saw a signif icant increase in lunrinal Ll in c:rse of persistcnt ecid
rcf lux, r 'u 'hereas in casc of el irninated acicl ref lur no signif icant chenge was observecl.  Thcre
rvas an increase of crvpt LI in both groups, stat ist icir l ly not dif ferent frorn each other. ln the
irroxinral lv taken biopsies l trn-r inal Ll i r-rcreased somer'vhat cluring pcrsistetrt  ref lux, but not
signif icantlv so; agl in in t fre group-r withor-rt  ref lux i t  renrained stablc. Crrpt Ll how'evcr
ir-rcreased signif icantlv in the omepruzole trc'ated group. El irnination of :rcicl  ref lrrx for nvcr
)ears thus l .racl r beneflcial ef lèct on cel l  prol i fèret ion with lcss l .r lol i fèrat ior.r in the l trnrir .r ir l
part and tnore of the prol i fèrat ion confined to thc crypts of Barrett 's epithel ium. This
pre\.ention of a f irr thcr incrcmc of prol i fèrat ivc xcrivi ty at thc luminrl  side of BO may
indicate l  recluct ion of canccr r isk.
ln a large pcrccnta.qe of BO u.i th l .r ieh-eracle dysplasia and in adenocarcinotna of the
oesophagus imn'runohistochemical overexpl 'ession of p53-protcin is fbLrnd, whereas this is
lerely found in nor.r-dvsplastic I l () .  Dr-rr ing oncogenesis genomic instabi l i ty .rr ises.
Mut:rt ion of the tumor suppressor ee ne p5:l  cln lcad to dvsfirnct ion oít the genc and to
imnrunohistochenrical overcxpression ol 'p53-protein. Bv slowinq clown prol i fèrat ive
activirv the occurrence of rntrtat ions, plrt icularly of the p53 gene rnieht be averted. C)f thc,













gro\\,rh frrctor-Cl (l'GF-cx) and of the epidermal growth Íàctor receptor (L,CF-r), again ir.r
paticnts rvho were trcared for two vears with either high dose omeprazole or coltvcl l t ional
closc rar-r i t idinc, so oÍrc group with acici ref lr-rx el iminatccl ,rncl another lvi th persistent acid
ref. lux. lr .r  ChapterVIII  rve prescnt our results. In notre of the 109 basel ine Lriopsies
crverexpression of p53-protein was obscrved. AÍ-rer 24 months, :rgain in the orneprlz.olc
treatec'l as u.cll as in rhe ranitidine trc:rted group no overexpression r,vas Found. No high-
erade dvsplasia lvas presenr in the basel ine biopsies since this wns ntr cxclusion crircr ion; et
24 rnonths no high,grade clysplasia was Í-ound in any of the biopsies either. With t l .rese
resulrs we c: lnnor tel l  rvhether acid ref lux el imir-rat ion can prevent mll tr t iotts in the p53
gene . Determination of l 'GF-Cr and EGF-r expression was done only in the 24 ntonth
biopsies. TGF,-CI expression was sienif icantlv stronger at the surÊrce thar-r in thc crvpt; in
contrast rvi th other ar. lrhors we Íround a stronger cxpression in glstr ic tvpe nre taphsia rgherr
ip inrestinal tvpe. ' l 'his mieht be dr-re to t l ' re acicl strppressive therapy, Pttt t i Írs a check on cel l
prol i fèrat ion in ir-rtest inal nretaplasia in part icular. Tfrcre was horvever no siqnif lcant
dif lèrence berw,een thc nvo rreatment grolrps. L,GF-r expression shorvecl o'en less variet iotr.
EGF-r expression in gastr ic type metaplasia was weaker in the orncprazole-trcated grott l-r
than in the ranit idir.re group. C)r,eral l  we cl id not frncl a signif icrnt int luence of acid ref lux
cl imination on rhe expression of T(lF-u ancl EGF-r. l r i ther thcre is no such i tr f lucnce' or
tl-re observed exPrcssion is tl-re lesult of a nut-nber of mech:rnist-t-ts w'ith op-rposite cflècts.
A nerv es;rcct in the clisclrssion on p:rthogencsis of BO is the rolc of ilte fIe/icobacter
p1/ori bacteritLm, especiirlh, the rzg,4-positive strait-t. Rece nt epidcrliological sttrclies f:rvoltr rr
protective rolc of H.il'/,,ri against sevcre GC)RI)' BC) anc'l adenocarcinoma of the
oesophagus and the cardia, wlrercas H.p.y/ori  s regarded to be a nr:r l iguancv pr.nttrt i trq
fàctor Íbr sastr ic cancer of rhe dif Í i rse ancl the intest inal typc [12] and f irr  MAl. l i rma of the
sronr:rclr.  The role of H.pylori  in uncornpl icatecl GC)RD is st i l l  not clerr,  clespite some
provocrrive :rrr icles, report ing that er:rdicati t tn of H.pylori  would increase rhc inci. lcncc oi
oesophagit is. Horvever, other inr.est igltors could not conflrm these observ:rt iotts. Moreover
eradicarion would rendcr the pH-increasing effect intra-sastr ical l ,v of acicl suppressive
nredicarion less effectivc. 
'We investigatcd whether there was a diflèrcrrce L.env.etr H.pylori-
neqrrive tnd H.py/ori-positive patients rcgarding symptorls of GOR and perccntage of acid
reflux per 24 hor-rrs, and wherher there was a diflèrcr-rce berwee n the nvo cluring treatÍncnt
rvith ontepr:rzole or ranit idine . ln Chapter IX rve prescnt the results. I)at ients, who rvere
H.plhri-pc>srtive or H.pylorl-ncgative based on a seruÍ.n IgG ELISA, rvere treated with
ornepr,rzolc 40 mg b.i .d. or with ranit idine 150 mg b.i .c1.. They were intt :rviewccl fbr their
( iOR svmptoms ancl trndcru,ent 24hour pH-nrctrv rrt  nvo occasions (at basel ine and
cluring therapy). Ar basel ine oesophageal acid exposure and GC)R symPtoms cl icl  not c{ i f lèr
benveen the H.p1/p7i-llegarive and the H.p4lori-1'tLtsitive paticnts. 
'II'eirtment lvith the rw<r
acicl suppressive drr"rgs resulted as expected in almost el iminlt ion of acid ref lrrx in the
omeprazole eroup, ar-rd a sr-nal ler reduction in acid ref lux in the ranit idine group. There u'as
howevcr r-ro sisnif- icant dif ference in either treatment group benvee n H.pylori-negative and
H.p.ylori-posïtlve parirnrs. As f-or the course of synrptoms during therapy, no significant
differerrce was observec'l berween the two grolrps. It is therelrore not ncccssrln\r to rnoclify the
medic:rt ion dosage becausc of the H.py/ori  status in the trcatment of patients rvith G()l lD.
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Su mma ry, conctusions u o.:r';l.[lïJ
\ i7i th respcct to B:rrrett 's ocsophagus mílny questions hlvc nor been ansrvered yet. Whv
clo sot-ne develop columnar nrctaplesi:r in t l -re oesopl-raglrs i l  i l  consequcnce of girstro-
ocsopl 'rageir l  ref j trx? As a grol lp thcsc patients havc nrore e.: icl  ref lux. accorcl ing to some
tnore duoclcnrr l  rcf lux, morc of ien a hiarel hcrr-r ia, and nrore of ien irnpairecl pcristalsis ancl
lorver oesophageal sphincter functior.r.  The quanti ty of acicl ref ' lux is undoubtedly an
inrportant fàctor-.  This is confirrned b1' rhe olrservarion rhr[ syrnpromaric (IORD itsclf  is a
strong r isk fàctor for oesophaqerrl  adcno.,rrcinorn.r [13]. Bur more lrrcrors nrusr be involvecl
in the prthoqenesis bccrruse of thc comparable scverity of ref lux in paticr-rts with severe
<rescrplraeitis but with,rut Barrert's rnctaplasia Ii4]. What is the role of Hc/icobrtcter p1,/ori,
especial l l '  of the nryA-y-tosit ive str:r in [15]? l ts prescnce seeÍns to protcct r lsainst oesopl-ragit is
encl adenocarcinomrr of the oesophagus [16-19]. Two recent reports, however, cor-r ld not
confirrn this protective ef lèct of H.pylot i  against rcf lux discase [20,]1].  Maybc therc is alscr
e Í:rnri l i l l  cor).st i tut i()r l i l l  f tctor [22,]31. The group at r isk Íbr,rclenocarcirrornrr is betrcr
deflnccl norv, since wc knorv that only special iz-ed-intestinal metaplasia is the culpri t .  ( lan
we .tcccl l tuate scrcenitrg arrd sr-Lrvei l l :rnce? Is survei l lance scnsible or useless? ()pinions on
this rnetter cliffèr. N'lo.st of the oc.sophegeal arrd cardia rrclcnoc:u'cinomas are cliagnosed when
thev are syt-npton-ratic ancl in an adr.ar-rced staqe. Only a small minority of known B()
p: l t ients c{ies of aclenocercir.ronra [24]; on thc other hand survei l lance results in earl ier
dctccrion ancl hcncc a rnore fà." 'ourable tumor.stagc xt the t ime of diagno.sis and better '
chrtnces lor survir ' :r l  125,26). f)o we l .rave to remove the rnetaplastic epithel iunr? Mucosal
ablat ion by anv of the usecl methods ( lase r coagulat ion, :rrgon be:rmer coagulat ion, hcate r
probe, photo-d1'nlmic rhcrepl ')  in conrl"; ination ' i th protorl  pump inhibitors fbr acid
st-tppression looks prornisirre. ' l 'his rvoulci also mcírn that survei l lance could be just i f- iecl for
those n'ho are regarclecl unflt fbr surgical treatrne nt but can stand endoscopic theraPr'. Ilut
t l r is rreltment moclal i ty h:rs cor-npl ic:rt ions, and in addir iorr to t tr i .s in ebout. l09ó rcmnilnts
of intcst inal rnetaplasir were f irur.rd hidden Lrnder squrmous epithel ium [8,9,11]. 'Síe necc{
a longcr fbl low-up to recomrrlend this as a standa.rd procedure. A largc prospective tr ial
woulcl be prcfèr'able, comparing a) ecicl reflux elimin:rtion; b) mucos,rl ablarion rvith rcflrrx
el inr ir .rat ior.r l  ar.rd c) aciecluate control of ref lux oesophagit is, with hiqh-grade dysplasia and
c:rrcinon-n as enclpoints.
A practical quidel ine for prcsent-dav pi l t icnt care may be to perform upper g.rstro-
ir-rtestinirl endoscopy rrt least once in case of longstancling (which means more than 5 years)
C;ORD, or i [ thc paricnt is oider than 50 years; i [ there is Barrett 's meraplasia oÍ:thc
.spcciali.secl-intestinal q'pe q'ithor-rt tlvsplasia to repeat endt',sco1',v after one year r',,hen newlv
diaenosed, than everr,- 2 to 3 years; if there ir 1s$'gracle dvsplasia as a ncw Í'inding to repeat
it afte r (r t-t'totrths :rnc{, when stablc, thcn eve ry year; if there is high-grtrcle dysplasia as a new
finding to repeat enck>sco1,y af icr 3 months Í irr  confir 'mation. l f  high-grade dvsplasia is st i l l
present, surgical resection shoLrld be considercd seriously; ancl i f  resection is not lreasible
errdoscopric mucosal abl:rt ior.r is an option, Íbr the t inre being preferably'wirhin .r sru. ly
prctocol. C)bviou.sly acicl suppressive therapy must be given to those with GORD
syÍnptoms. There are good reasons to treat patients without clear syn-rptoms too: the
patient rnay not have recognized his symptorns suff iciently as GOR-related. Ancl
elimin:rtiorr of acid tasrro-oe.sophrrgeal reflr,rx appear.s to be firr,otrrable íor metaplastic
Batrett 's epithel iunr.
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